Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Denham

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
The Lancet. Oncology|June 2, 2007
MRC RT01: an important trialJames W Denham
Nature Reviews. Clinical Oncology|August 17, 2011
Targeted therapies: An important piece of the localized prostate cancer puzzle?James W Denham
Seminars in Radiation Oncology|June 15, 2013
Picking the optimal duration of hormonal therapy in men with high-risk and locally advanced prostate cancer treated with radiotherapyJames W Denham, Allison Steigler
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2002
The radiotherapeutic injury--a complex 'wound'James W Denham, Martin Hauer-Jensen
Lancet (London, England)|September 27, 2013
Radiation induced bowel injury: a neglected problemJames W Denham, Martin Hauer-Jensen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Value of combined androgen blockade in the neoadjuvant treatment of localized prostate cancer: the jury must remain outMahesh Kumar, James W Denham, Allison Steigler
Seminars in Radiation Oncology|August 7, 2003
Bowel injury: current and evolving management strategiesMartin Hauer-Jensen, Junru Wang, James W Denham
Journal of Toxicologic Pathology|October 7, 2015
Histopathology and oxidative stress analysis of concomitant misoprostol and celecoxib administrationDerek E Murrell, James W Denham, Sam Harirforoosh
Psycho-Oncology|May 16, 2014
Factors associated with feelings of loss of masculinity in men with prostate cancer in the RADAR trialChristopher F Sharpley, Vicki Birsika, James W Denham
Oncology|February 8, 2012
Androgen deprivation therapy for prostate cancer does not increase cardiovascular mortality in the long termChantelle Wilcox, Allison Kautto, Allison Steigler, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
The Lancet. Oncology|June 2, 2007
MRC RT01: an important trialJames W Denham
Nature Reviews. Clinical Oncology|August 17, 2011
Targeted therapies: An important piece of the localized prostate cancer puzzle?James W Denham
Seminars in Radiation Oncology|June 15, 2013
Picking the optimal duration of hormonal therapy in men with high-risk and locally advanced prostate cancer treated with radiotherapyJames W Denham, Allison Steigler
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 14, 2002
The radiotherapeutic injury--a complex 'wound'James W Denham, Martin Hauer-Jensen
Lancet (London, England)|September 27, 2013
Radiation induced bowel injury: a neglected problemJames W Denham, Martin Hauer-Jensen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Value of combined androgen blockade in the neoadjuvant treatment of localized prostate cancer: the jury must remain outMahesh Kumar, James W Denham, Allison Steigler
Seminars in Radiation Oncology|August 7, 2003
Bowel injury: current and evolving management strategiesMartin Hauer-Jensen, Junru Wang, James W Denham
Journal of Toxicologic Pathology|October 7, 2015
Histopathology and oxidative stress analysis of concomitant misoprostol and celecoxib administrationDerek E Murrell, James W Denham, Sam Harirforoosh
Psycho-Oncology|May 16, 2014
Factors associated with feelings of loss of masculinity in men with prostate cancer in the RADAR trialChristopher F Sharpley, Vicki Birsika, James W Denham
Oncology|February 8, 2012
Androgen deprivation therapy for prostate cancer does not increase cardiovascular mortality in the long termChantelle Wilcox, Allison Kautto, Allison Steigler, et al.
Pageof 10